Ring Therapeutics
Avak Kahvejian is an accomplished biotech entrepreneur and investor, currently serving as the Founding CEO of Abiologics since March 2021 and a General Partner at Flagship Pioneering since July 2011. Kahvejian holds leadership positions as a Board Member and Founding CEO in multiple organizations, including Ampersand Biomedicines, ProFound Therapeutics, Sail Biomedicines, Cellarity, and Ring Therapeutics, with roles as Chairman of the Board at Ring Therapeutics. Additional experience includes founding co-CEO of Generate Biomedicines, Chief Innovation Officer, and Founding President & CEO at Cygnal Therapeutics. Kahvejian earned a Ph.D. in Biochemistry and a B.Sc. in Biochemistry, Honors from McGill University, further informing expertise in the biotech field.
This person is not in the org chart
This person is not in any teams
Ring Therapeutics
Ring Therapeutics' Anellogy™ platform aims to usher in a new era of gene therapy using the human commensal virome.